Madrigal Pharmaceuticals, Inc. (MDGL): Price and Financial Metrics

Madrigal Pharmaceuticals, Inc. (MDGL): $222.14

6.20 (-2.72%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

MDGL Price/Volume Stats

Current price $222.14 52-week high $322.67
Prev. close $228.34 52-week low $119.76
Day low $220.74 Volume 160,785
Day high $227.90 Avg. volume 523,706
50-day MA $241.42 Dividend yield N/A
200-day MA $201.99 Market Cap 4.42B

MDGL Stock Price Chart Interactive Chart >


Madrigal Pharmaceuticals, Inc. (MDGL) Company Bio


Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of cardiovascular, metabolic, and liver diseases. The company was founded in 2011 and is based in Fort Washington, Pennsylvania.


MDGL Latest News Stream


Event/Time News Detail
Loading, please wait...

MDGL Latest Social Stream


Loading social stream, please wait...

View Full MDGL Social Stream

Latest MDGL News From Around the Web

Below are the latest news stories about MADRIGAL PHARMACEUTICALS INC that investors may wish to consider to help them evaluate MDGL as an investment opportunity.

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

CONSHOHOCKEN, Pa., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that the company granted equity awards to thirty-two new employees with a grant date of December 19, 2023 as equity inducement awards outside of the Company’s Amended 2015 Stock Plan under the terms of the company's 2023 Inducement Plan. The equity awards were approved in

Yahoo | December 22, 2023

Senior VP Robert Waltermire Sells 4,000 Shares of Madrigal Pharmaceuticals Inc (MDGL)

In a recent transaction on December 15, 2023, Robert Waltermire, Senior Vice President and Chief of Pharmaceutical Development at Madrigal Pharmaceuticals Inc, sold 4,000 shares of the company's stock.

Yahoo | December 19, 2023

11 Stocks Insiders and Billionaires Are Crazy About

In this article, we will take a detailed look at the 11 Stocks Insiders and Billionaires Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks Insiders and Billionaires Are Crazy About. In his famous book titled One Up on Wall Street, Peter Lynch talks about how average investors miss out on opportunities by […]

Yahoo | December 19, 2023

Madrigal Pharmaceuticals, Inc.'s (NASDAQ:MDGL) Shift From Loss To Profit

Madrigal Pharmaceuticals, Inc. ( NASDAQ:MDGL ) is possibly approaching a major achievement in its business, so we would...

Yahoo | December 17, 2023

Insider Sell Alert: Senior VP Robert Waltermire Sells 3,800 Shares of Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) has recently witnessed a significant insider sell that has caught the attention of investors and market analysts.

Yahoo | December 16, 2023

Read More 'MDGL' Stories Here

MDGL Price Returns

1-mo -16.39%
3-mo -1.92%
6-mo 68.88%
1-year -24.23%
3-year 83.30%
5-year 110.44%
YTD -3.99%
2023 -20.28%
2022 242.52%
2021 -23.77%
2020 22.02%
2019 -19.17%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!